Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
Aegis is pleased to announce that following a rigorous review process, it will continue to participate as a UnitedHealthcare Preferred...
We are pleased to announce the results of its 2025 Client Satisfaction Survey. Respondents affirmed that our services make a...
NASHVILLE, TN. (July 7, 2025) – Aegis Sciences Corporation is pleased to announce our partnership with Jeff Konin, Ph.D., ATC....
NASHVILLE, Tenn. (July 1, 2025) – Aegis Sciences Corporation, a leading healthcare and forensic toxicology laboratory, today announced the kick-off...
Aegis Sciences Corporation today announced the successful completion of a $170 million debt refinancing...
Sign up for the Aegis Newsletter